ESC Gold Medals

Emeritus Professor at the Department of Cardiovascular Sciences, KU Leuven.

Director of the Centre for Cardiac Arrhythmias of Genetic Origin and of the Laboratory of Cardiovascular Genetics at the Istituto Auxologico Italiano, IRCCS, Milan, Italy. 

Distinguished Scholar in Cardiovascular Science at Baylor University Medical Centre, Dallas, Texas and Visiting Professor at Imperial College, London, UK.   

Clinical cardiologist and translational researcher at the Amsterdam University Medical Centre (AUMC), Amsterdam, The Netherlands. 

Professor at Istituti Clinici Scientifici Maugeri, Pavia, Italy. 

 Professor emeritus of the University of Michigan School of Medicine, Ann Arbor, Michigan. 

President of the European Center for Cardiovascular Research (CERC), Massy, France. 

Vice President of the International University of Health and Welfare, and Professor of the Department of Frontier Cardiovascular Science at the University of Tokyo, Tokyo, Japan. 

Professor of cardiovascular research at Karolinska Institute and Karolinska University Hospital in Stockholm, Sweden.  

Internationally renowned cardiovascular pathologist, recognised as a leading researcher in the field of cardiovascular disease treatments. 

Professor of Cardiology at the University of Leicester and consultant cardiologist at Glenfield Hospital, Leicester, UK. 

He was a Japanese biochemist whose research into the relationship between fungi and cholesterol biosynthesis led to the development of statin drugs, which are some of the best-selling pharmaceuticals in history. 

Icelandic neurologist and founder and CEO of Reykjavik-based deCODE genetics. 

Professor of Medical Cardiology and Deputy Director (Clinical) of the Institute of Cardiovascular and Medical Sciences and honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow, Scotland.

German biologist specialising in the pathophysiological processes underlying cardiovascular diseases.

Christine Seidman is the Thomas W. Smith Professor of Medicine and Genetics at Harvard Medical School, an Investigator of the Howard Hughes Medical Institute, and Director of the Cardiovascular Genetics Service at Brigham and Women’s Hospital. She was an undergraduate at Harvard College and received a M.D. from George Washington University School of Medicine. Dr. Seidman served as an intern and resident in Internal Medicine at John Hopkins Hospital and received subspecialty training in cardiology at the Massachusetts General Hospital.

Dr. Seidman has pioneered the discovery of the genetic basis for heart muscle disorders, including hypertrophic and dilated cardiomyopathies and congenital heart disease. By engineering human mutations into iPSC-derived cardiomyocytes and mouse models she has identified molecular mechanisms and therapeutic targets. Her work has enabled development of clinical gene-based diagnostics, early and accurate identification of at-risk individuals, and pre-emptive interventions to limit the progression and devastating outcomes associated with these disorders.

Dr. Seidman is the recipient of the American Heart Association Basic Science Prize and Joseph A. Vita Award, the American Society for Clinical Investigation Award, the Pasarow Foundation Award in Cardiovascular Research, the Bristol-Myers Squibb Award for Distinguished Achievement in Cardiovascular Research and the Institut de France Fondation Lefoulon-Delalande Grand Prix for Science Award. She is a member of U.S. National Academy of Medicine and the National Academy of Science.

Professor of Internal Medicine, Director of the Department of Internal Medicine III (Cardiology, Angiology, Pneumology) and Head of Internal Medicine at the University of Heidelberg in Germany. 

Chief Science and Medical Officer of the American Heart Association and Emeritus Professor of Medicine at the University of Pennsylvania School of Medicine, Philadephia, USA.  

Director General of the Almazov National Medical Centre (St. Petersburg, Russia) and President of the Russian Society of Cardiology.

Dzau Professor of Medicine at Harvard Medical School, and Senior Physician in the Cardiovascular Division at the Brigham and Women’s Hospital in Boston, Massachusetts. 

Professor of Medicine (Emeritus) in the Division of Cardiovascular Diseases at Stanford University's School of Medicine and Director of Ethics and Policy for Stanford's Biodesign Innovation Fellowship, Stanford, California. 

Professor of Cardiology at the University of Edinburgh, UK and British Heart Foundation Professor (both Emeritus). 

Head of the Cardiocenter at the University Hospital "Kralovske Vinohrady" in Prague, Czech Republic.  

BHF Professor of Medicine and Epidemiology at the BHF Centre of Research Excellence, University of Oxford, Clinical Trial Service Unit & Epidemiological Studies Unit, Oxford, UK. 

Established Professor of Interventional Medicine and Innovation at National University of Ireland, Galway, Ireland. 

Honorary professor at the University of Tokyo, Tokyo, Japan. 

CEO of Medical Centre Prof Brugada (Aalst), Scientific Director at UZ Brussel, internationally active electrophysiologist. 

Cardiovascular specialist at Brigham and Women’s Hospital in Boston, Massachusetts, he holds the Mallinckrodt Professorship of Medicine at Harvard Medical School. 

Professor of Cardiology at Uppsala University Hospital, Uppsala, Sweden.  

He was a French cardiac surgeon best known for performing Europe's first heart transplant at Pitié Salpêtrière Hospital in 1968, Paris, France. 

He was a British research cardiologist and an Honorary Consultant Physician at the John Radcliffe Hospital in Oxford and the Oxford University Hospitals NHS Foundation Trust, Oxford, UK. 

 Senior Professor of Cardiology at the department of cardiovascular sciences of the University of Leuven, Leuven, Belgium.

Scientific Consultant for Maria Cecilia Hospital – GVM Care&Research, Cotignola, Italy.  

He served as a Distinguished Professor at the Keck School of Medicine, University of Southern California. He was credited for his contribution to two clinical syndromes namely the hibernating myocardium and 'prosthetic valve-mismatch'.  

Distinguished University Professor of Medicine at McMaster University and Executive Director of the Population Health Research Institute, Canada. He holds a Heart and Stroke Foundation of Ontario Research Chair and in 2023 was elected as an Honorary Fellow of St. John’s College, Oxford, UK. 

British emeritus professor of cardiology at Imperial College, London, UK, who is best known for defining the concept and subspecialty of grown ups with congenital heart disease (GUCH) and being chosen as the physician involved with Britain's first heart transplantation by Donald Ross in 1968.